BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 29188564)

  • 1. Molecular Basis of Ligand Dissociation from G Protein-Coupled Receptors and Predicting Residence Time.
    Guo D; IJzerman AP
    Methods Mol Biol; 2018; 1705():197-206. PubMed ID: 29188564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches for Differentiation and Interconverting GPCR Agonists and Antagonists.
    Miszta P; Jakowiecki J; Rutkowska E; Turant M; Latek D; Filipek S
    Methods Mol Biol; 2018; 1705():265-296. PubMed ID: 29188567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
    Rodríguez D; Gutiérrez-de-Terán H
    Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Use of GPCR Modeling and SDM Experiments to Understand Ligand Binding.
    Potterton A; Heifetz A; Townsend-Nicholson A
    Methods Mol Biol; 2018; 1705():335-343. PubMed ID: 29188570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPCRs: What Can We Learn from Molecular Dynamics Simulations?
    Velgy N; Hedger G; Biggin PC
    Methods Mol Biol; 2018; 1705():133-158. PubMed ID: 29188561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating Small-Molecule Ligand Binding to G Protein-Coupled Receptors with Biased or Unbiased Molecular Dynamics Simulations.
    Marino KA; Filizola M
    Methods Mol Biol; 2018; 1705():351-364. PubMed ID: 29188572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodologies for the Examination of Water in GPCRs.
    Bortolato A; Tehan BG; Smith RT; Mason JS
    Methods Mol Biol; 2018; 1705():207-232. PubMed ID: 29188565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C; Angelloz-Nicoud P; Pihan E
    Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
    Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
    Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery.
    Zou Y; Ewalt J; Ng HL
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Do Molecular Dynamics Data Complement Static Structural Data of GPCRs.
    Torrens-Fontanals M; Stepniewski TM; Aranda-García D; Morales-Pastor A; Medel-Lacruz B; Selent J
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
    Cross JB
    Methods Mol Biol; 2018; 1705():233-264. PubMed ID: 29188566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.
    Segala E; Guo D; Cheng RK; Bortolato A; Deflorian F; Doré AS; Errey JC; Heitman LH; IJzerman AP; Marshall FH; Cooke RM
    J Med Chem; 2016 Jul; 59(13):6470-9. PubMed ID: 27312113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Ligand Binding to GPCRs Through Computational Methods.
    Vasile S; Esguerra M; Jespers W; Oliveira A; Sallander J; Åqvist J; Gutiérrez-de-Terán H
    Methods Mol Biol; 2018; 1705():23-44. PubMed ID: 29188557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-protein coupled receptors: advances in simulation and drug discovery.
    Miao Y; McCammon JA
    Curr Opin Struct Biol; 2016 Dec; 41():83-89. PubMed ID: 27344006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Computational Techniques to Study GPCR-Ligand Recognition.
    Ciancetta A; Sabbadin D; Federico S; Spalluto G; Moro S
    Trends Pharmacol Sci; 2015 Dec; 36(12):878-890. PubMed ID: 26538318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensemble Docking in Drug Discovery: How Many Protein Configurations from Molecular Dynamics Simulations are Needed To Reproduce Known Ligand Binding?
    Evangelista Falcon W; Ellingson SR; Smith JC; Baudry J
    J Phys Chem B; 2019 Jun; 123(25):5189-5195. PubMed ID: 30695645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and Opportunities in Drug Discovery of Biased Ligands.
    Rodríguez-Espigares I; Kaczor AA; Stepniewski TM; Selent J
    Methods Mol Biol; 2018; 1705():321-334. PubMed ID: 29188569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding Kinetics and Pathways of Ligands to GPCRs.
    Strasser A; Wittmann HJ; Seifert R
    Trends Pharmacol Sci; 2017 Aug; 38(8):717-732. PubMed ID: 28645833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.